PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview

被引:6
|
作者
Caracciolo, Matteo [1 ]
Castello, Angelo [2 ]
Lopci, Egesta [3 ,4 ]
机构
[1] Univ Hosp Ferrara, Oncol Med & Specialists Dept, Nucl Med Unit, Ferrara, Italy
[2] Fdn IRCCS CaGranda, Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
[3] IRCCS, Human Res Hosp, Nucl Med Unit, Milan, Italy
[4] IRCCS, Human Res Hosp, Nucl Med Unit, Via Manzoni 56, I-20089 Milan, Italy
关键词
GA-68-PSMA PET/CT; DIAGNOSTIC-ACCURACY; BIOPSY; VALIDATION; MRI; PSA;
D O I
10.1053/j.semnuclmed.2023.10.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In the last years, PSMA-PET imaging and multiparametric MRI (mpMRI) have improved the clinical management of prostate cancer (PCa) patients. Currently, mpMRI is recommended by the EAU (European Association of Urology) guidelines for the primary diagnosis of PCa, whereas PSMA-PET is reserved for disease staging, particularly in high risk localized or locally advanced disease, as well as for biochemical recurrence after surgery. Nevertheless, several studies have explored the added value of PSMA-PET in other clinical scenar-ios, including primary diagnosis and especially for the detection of clinically significant PCa (csPCa). In the present contribution, we will provide an overview and an update on the cur-rent literature on imaging detection of csPCa, with a particular focus on mpMRI, PSMA-PET and their comparison. Semin Nucl Med 54:30-38 (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [21] PRIMARY scores on PSMA PET/CT and MpMRI: Role in initial evaluation of prostate cancer.
    Kumar, S.
    Mathur, Y.
    Singh, H.
    Mittal, B.
    Kumar, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S177 - S177
  • [22] Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [68Ga]PSMA-11-PET and [11C]Acetate-PET
    Sandgren, Kristina
    Strandberg, Sara N.
    Jonsson, Joakim H.
    Grefve, Josefine
    Lindberg, Angsana Keeratijarut
    Nilsson, Erik
    Bergh, Anders
    Soderkvist, Karin
    Thellenberg Karlsson, Camilla
    Friedrich, Bengt
    Widmark, Anders
    Blomqvist, Lennart
    Berg Loegager, Vibeke
    Axelsson, Jan
    Ogren, Mattias
    Ogren, Margareta
    Nyholm, Tufve
    Riklund, Katrine
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (11) : 997 - 1004
  • [23] COMBINATION OF 68GA-PSMA PET/CT AND MULTIPARAMETER MRI IMPROVES THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A LESION BY LESION ANALYSIS
    Chen, Mengxia
    Zhang, Qing
    Zhang, Chengwei
    Zhao, Xiaozhi
    Marra, Giancarlo
    Gao, Jie
    Lv, Xiaoyu
    Zhang, Bing
    Fu, Yao
    Wang, Feng
    Qiu, Xuefeng
    Guo, Hongqian
    JOURNAL OF UROLOGY, 2019, 201 (04): : E185 - E185
  • [24] Convoluted Neural Network for Detection of Clinically Significant Prostate Cancer on 68 Ga PSMA PET/CT Delayed Imaging by Analyzing Radiomic Features
    Rajender Kumar
    Arivan Ramachandran
    Bhagwant Rai Mittal
    Harmandeep Singh
    Nuclear Medicine and Molecular Imaging, 2024, 58 : 62 - 68
  • [25] Convoluted Neural Network for Detection of Clinically Significant Prostate Cancer on 68 Ga PSMA PET/CT Delayed Imaging by Analyzing Radiomic Features
    Kumar, Rajender
    Ramachandran, Arivan
    Mittal, Bhagwant Rai
    Singh, Harmandeep
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 58 (02) : 62 - 68
  • [26] Can SUVmax Values of 68Ga-PSMA PET/CT scan Predict the Clinically Significant Prostate Cancer
    Sahin, O. E.
    Akgun, E.
    Demirci, E.
    Gultekin, M.
    Doganca, T.
    Tuna, M.
    Obek, C.
    Kilic, M.
    Esen, T.
    Kural, A.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S525 - S526
  • [27] Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
    Demirci, Emre
    Kabasakal, Levent
    Sahin, Onur E.
    Akgun, Elife
    Gultekin, Mehmet Hamza
    Doganca, Tunkut
    Tuna, Mustafa B.
    Obek, Can
    Kilic, Mert
    Esen, Tarik
    Kural, Ali R.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (01) : 86 - 91
  • [28] PSMA PET- and mpMRI-directed Prostate Cancer Salvage
    Liu, Wei
    Bauman, Glenn
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1053 - 1054
  • [29] Detection and Local Staging of Prostate Cancer by [68Ga]Ga-PSMA-PET/CT, Comparison with mpMRI and Histopathology
    Isik, Z.
    Guner, G.
    Caglar, M.
    Karcaaltincaba, M.
    Akdogan, B.
    Akinci, D.
    Tuncel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S23 - S24
  • [30] Diagnostic Accuracy of 68GA-PSMA PET and MPMRI to Detect Intra-Prostatic Clinically Significant Prostate Cancer Using Whole-Mount Pathology. Impact of the Addition of 68GA-PSMA PET to MPMRI?
    Amin, Amer
    Stricker, Phillip
    Scheltema, Matthijs
    Blazevski, Alexandar
    Chang, John
    van Leeuwen, Pim
    Quoc Nguyen
    Ho, Bao
    Delprado, Warick
    Lee, Jonathan
    Cusick, Thomas
    Spriensma, Alette
    Siriwardena, Amila
    O'Neill, Gordon
    Yuen, Carlo
    Kooner, Raji
    Hruby, George
    Thompson, James
    Emmett, Louise
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 42 - 42